According to Pliant Therapeutics's latest financial reports the company's current EPS (TTM) is -2,49 โฌ. In 2022 the company made an earnings per share (EPS) of -2,69 โฌ a decrease over its 2021 EPS that were of -2,46 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -2,59 โฌ | -3.83% |
2022 | -2,69 โฌ | 9.59% |
2021 | -2,46 โฌ | 12.92% |
2020 | -2,18 โฌ | 664.17% |
2019 | -0,28 โฌ |